Dexmedetomidine Versus Dexamethasone as an Adjuvant in TAP Blocks for Cesarean Section: A Meta-Analysis of Randomized Clinical Trials
Current Anesthesiology Reports · 05.08.2026 · 16 (1)
DOI: 10.1007/s40140-026-00721-3 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Current Anesthesiology Reports, online erschienen am 05.08.2026. Verfasst von Marcela da Silva Kazitani Cunha und 10 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Cesarean Delivery (CD) often causes moderate to severe postoperative pain. The transversus abdominis plane (TAP) block reduces somatic pain after lower abdominal surgeries; however, its duration is limited when local anesthetics are used alone. Adjuvants like dexmedetomidine and dexamethasone are used to prolong analgesia, but their comparative efficacy in TAP block for CD remains uncertain.
Methods
We systematically searched PubMed, Embase, and Cochrane databases for randomized controlled trials (RCTs) comparing dexmedetomidine and dexamethasone as adjuvants in patients undergoing CD. Primary outcomes were postoperative pain scores (VAS) and time to first analgesia request. Secondary endpoints included heart rate (HR) and postoperative nausea and vomiting (PONV). Pooled mean differences (MD) and risk ratios (RR) were calculated with 95% confidence intervals (CI) using a random-effects model.
Results
Six RCTs comprising 460 patients were included, with 230 (50%) receiving dexmedetomidine. Compared with dexamethasone, dexmedetomidine significantly reduced VAS at 4 h (MD -0.88; 95% CI: -1.60 to -0.17; p = 0.016), while dexamethasone was superior at 24 h (MD 0.72; 95% CI: 0.02 to 1.42; p = 0.043). There were no significant differences for VAS at 12 h. Dexmedetomidine was associated with lower HR at 2 and 4 h and reduced the incidence of PONV (RR 0.19; 95% CI: 0.04 to 0.81; p = 0.025). Time to first analgesia request was similar between groups.
Conclusion
Our meta-analysis suggests that dexmedetomidine provided better early analgesia, lower HR at 2 and 4 hours and reduced PONV, while dexamethasone was more effective at 24 hours. Further RCTs are warranted to confirm these findings.
Zitieren
APA
Cunha, M. D. S. K., Barbosa, L. M., Silva, A. K. B. D., Ferreira, C. H. D. O., Nascimento, L. R. D., Bendaham, L. C. A. R., Peclat, T. R., Farber, M. K., Hirsch, J., Martins, E. G., & Moreti, N. M. (2026). Dexmedetomidine Versus Dexamethasone as an Adjuvant in TAP Blocks for Cesarean Section: A Meta-Analysis of Randomized Clinical Trials. Current Anesthesiology Reports, 16(1). https://doi.org/10.1007/s40140-026-00721-3
Vancouver
Cunha MDSK, Barbosa LM, Silva AKBD, Ferreira CHDO, Nascimento LRD, Bendaham LCAR, et al. Dexmedetomidine Versus Dexamethasone as an Adjuvant in TAP Blocks for Cesarean Section: A Meta-Analysis of Randomized Clinical Trials. Current Anesthesiology Reports. 2026;16(1). doi:10.1007/s40140-026-00721-3
BibTeX
@article{Cunha2026,
author = {Cunha, Marcela da Silva Kazitani and Barbosa, Lucas Mendes and Silva, Acza Kalica Buarque da and Ferreira, Carlos Henrique de Oliveira and Nascimento, Leonardo Reischoffer do and Bendaham, Lucas Cael Azevedo Ramos and Peclat, Thaís Ribeiro and Farber, Michaela K. and Hirsch, Jason and Martins, Elaine Gomes and Moreti, Natália Marques},
title = {Dexmedetomidine Versus Dexamethasone as an Adjuvant in TAP Blocks for Cesarean Section: A Meta-Analysis of Randomized Clinical Trials},
journal = {Current Anesthesiology Reports},
year = {2026},
volume = {16},
number = {1},
doi = {10.1007/s40140-026-00721-3}
}
EUVIMED